BridgeBio Pharma Inc <BBIO.O>: Citigroup raises target price to $93 from $82
BBIO•Related News
Morning Bid Americas-Damp Squib
SPY•
Shortsellers take aim at manufacturing in June amid supply chain stress, Hazeltree data shows
XLI•
Abbott raises 2026 profit forecast on heart device strength
ABT•
US probes Samsung for alleged infringement of Netlist's memory-chip patents
NLST•
Celanese Corp. <CE.N>: Morgan Stanley cuts target price to $58.00 from $72.00
CE•